Bottom line
Is LADYX a good fund? The bottom line
LADYX is the Class I share class of Lord Abbett Developing Growth Fund Inc, an actively managed large growth mutual fund from Lord Abbett.
Annual fees run 0.69% — about $69 a year on every $10,000 invested, cheaper than 68% of large growth funds we track.
It returned +22.2% over one year, +7.5% a year over five years, +8.8% a year over ten (as of Dec 31, 2024, per its prospectus).
With $2.2 billion in net assets and 95 holdings, its largest position is Guardant Health Inc (3.0%) and the top 10 make up 20.3% of the portfolio.
What stands out
- No front-end sales load
What to watch
- 5-year return in the bottom quarter of its category
- High turnover (112% a year) can mean more taxable distributions
Updated Nov 19, 2026
What LADYX invests in
The Funds investment objective is long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter.
The Fund invests in equity securities of companies that the portfolio management team believes demonstrate above-average, long-term growth potential. The portfolio management team seeks to identify companies that it believes are strongly positioned in the developing growth phase, which it defines as the period of swift development after a companys start-up phase when growth is expected to occur at a rate generally not equaled by established companies in their mature years. Under normal conditions, the Fund invests at least 65% of its net assets in equity securities of small companies. A small company is defined as a company having a market capitalization at the time of purchase that falls within the market capitalization range of companies in the Russell 2000 Index. Equity securities in which the Fund may invest include common stocks, preferred stocks, equity interests in trusts…
From the fund's prospectus (filed Nov 26, 2025).
LADYX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| LADYX | +22.2% | +7.5% | +8.8% |
| Large Growth median | +15.2% | +11.0% | +14.2% |
Source: Fund prospectus, as of Dec 31, 2024
What LADYX costs
On a $10,000 investment, LADYX's 0.69% expense ratio costs about $69 a year. The prospectus estimates $859 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.
LADYX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Guardant Health Inc | 2.95% |
| 2 | Navan Inc | 2.38% |
| 3 | Fixed Income Clearing Corp. | 2.11% |
| 4 | JFrog Ltd | 1.99% |
| 5 | DigitalOcean Holdings Inc | 1.94% |
| 6 | Cogent Biosciences Inc | 1.85% |
| 7 | IES Holdings Inc | 1.82% |
| 8 | Argan Inc | 1.79% |
| 9 | SiTime Corp | 1.73% |
| 10 | Lattice Semiconductor Corp | 1.71% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 20.3% of the fund. See all top 25 holdings and asset mix →